← Evidence map

ArticleBiochemical pharmacology2020

Corrigendum to "Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost" [Biochem. Pharmacol. 178 (2020) 114057].

Manar Mohammed El Tabaa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost" [Biochem. Pharmacol. 178 (2020) 114057]. | Socratic